Bulgaria - Bulgar - Изпълнителна агенция по лекарствата

abbvie s.r.l. - хлорхидрат levobupivacaine - 7,5 mg/ml solution for injection/concentrate for slution for infusion

Bulgaria - Bulgar - Изпълнителна агенция по лекарствата

abbvie deutschland gmbh & co.kg - Леводопа и инхибитори на декарбоксилазы - 20 mg/ml + 5 mg/ml intestinal gel

Bulgaria - Bulgar - Изпълнителна агенция по лекарствата

abbvie ltd - Природни фосфолипиди - 25 mg / ml endotracheopumonary inst. susp.

Bulgaria - Bulgar - Изпълнителна агенция по лекарствата

abbvie ltd - Изофлуран - 100 % inhalation vapour, liquid

Bulgaria - Bulgar - Изпълнителна агенция по лекарствата

abbvie ltd - Севофлуран - 100% inhalation vapour, liquid

Bulgaria - Bulgar - Изпълнителна агенция по лекарствата

abbvie ltd - Лейпрорелин - 3,75 mg powder and solvent for suspension for injection

Uni Eropa - Bulgar - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - upadacitinib - Артрит, ревматоиден - Имуносупресори - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.  crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.

Bulgaria - Bulgar - БАБХ (Българска агенция по безопасност на храните)

Вет Про Комерс ООД - Вирус денга хеморагична болест по зайци (rhdv), нига., rhdv щам phb98 - инжекционна суспензия - мин. 1 pd90 - зайци

Bulgaria - Bulgar - БАБХ (Българска агенция по безопасност на храните)

intervet international b.v - Вирус на бяс щам Пастьор ПИВ; interrogans лептоспир, инактивированная, серогруппы Кашницкого, щам sa-12-000; серогруппы icterohaemorrhagiae; прецежда се 820k - инжекционна суспензия - ≥ 40 pd80; ≥ 40 pd80 - кучета

Bulgaria - Bulgar - БАБХ (Българска агенция по безопасност на храните)

virbac - Вируса на бяс, инактивированной, щам vp12 - инжекционна суспензия - мин. 1 iu/ml - котки, кучета